Pet Medication Innovation Watch

New & Upcoming Pet Medicines

Track newly FDA-confirmed pet medications and publicly disclosed veterinary medicine development updates. Roxee shows a stage only when public evidence supports it.

Review tracked updates Browse approved medication catalog Talk to a Vet / Find a Vet Near You

Owner-safe availability note

Development-stage products may not be FDA-approved, available, or proven safe/effective. Availability timing is shown only when public source evidence supports it.

Veterinary professional?

Recently FDA-confirmed 76

In development 0

Clinical trial visible 0

Watchlist signals 0

Species

Status

Condition

Evidence

Availability

Clear

Tracked public updates

2 tracked updates

Every card separates FDA-confirmed status from sponsor, trial, regulatory-program, or research signals.

Recently FDA-confirmed FDA-confirmed

LIAVIUM™-CA1

LIAVIUM™-CA1 / pregabalin chewable tablets

Species: Dogs
Condition: Pain & arthritis
Sponsor: TriviumVet
Public stage: FDA approved
Availability: FDA approved, launch unclear

LIAVIUM™-CA1 is indicated for the management of pain and clinical signs associated with Chiari-like malformation and syringomyelia in dogs.

FDA-confirmed status means Roxee found public approval or market-status evidence. Ask your veterinarian whether this option applies to your pet.

Recently FDA-confirmed FDA-confirmed

felycin-CA1

felycin-CA1 / sirolimus delayed-release tablets

Species: Cats
Condition: Systemic hypertension
Sponsor: TriviumVet
Public stage: FDA approved
Availability: FDA approved, launch unclear

For the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM). Subclinical HCM refers to cats with left ventricular (LV) hypertrophy (LV wall thickness of ≥6 mm at end diasto...

FDA-confirmed status means Roxee found public approval or market-status evidence. Ask your veterinarian whether this option applies to your pet.